Endexx Corporation (EDXC)

Market Cap	59.36K -95.5%
Revenue (ttm)	4.64M +292.2%
Net Income	6.89M
EPS	0.01
Shares Out	593.61M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,025
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0401
Beta	-0.53
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Endexx

Endexx Corporation develops and sells hemp-derived products for the health and wellness market under the CBD Unlimited brand in the United States and internationally. The company offers cannabidiol oils, topicals, capsules, snacks, and beverages, as well as equine products for dogs and cats under the PhytoBites brand. It serves medical, biotech, and life science industries. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. The company is based in Cave Creek, Arizona.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: EDXC

Financial Performance

In fiscal year 2022, Endexx's revenue was $2.14 million, an increase of 228.66% compared to the previous year's $650,515. Losses were -$4.88 million, -28.26% less than in 2021.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error